About this trial
Evaluation of the safety and efficacy of a multi-branched thoracoabdominal stent graft system for thoracoabdominal aortic aneurysm.
Eligibility criteria
Qualifiers
18 years old ≤ age ≤ 80 years old;
Diagnosed as thoracoabdominal aortic aneurysm (based on modified Crawford classification and 2019 European Guidelines for the Treatment of Aortic aneurysm) and should meet at least one of the following conditions;
Maximum diameter of thoracoabdominal aortic aneurysm>50mm;
The diameter has increased by more than 5mm in recent 6 months or the by more than 10mm in recent 1 year;
Disqualifiers
Hemodynamically unstable patients with ruptured thoracoabdominal aortic aneurysms;
Thoracoabdominal aortic dissection;
Mycotic or infectious thoracoabdominal aortic aneurysm;
Patients whose systemic or local infection may increase the risk of intravascular graft infection;
Trial design
Treatments tested in this trial
- Multi-Branched Thoracoabdominal Stent Graft System